Literature DB >> 28776589

OCT Glaucoma Staging System: a new method for retinal nerve fiber layer damage classification using spectral-domain OCT.

P Brusini1.   

Abstract

PurposeTo describe a new method, the Optical Coherence Tomography (OCT) Glaucoma Staging System, for classifying retinal nerve fiber layer (RNFL) damage assessed with OCT.Patients and methodsThe OCT Glaucoma Staging System was created based on data obtained from Nidek RS 3000 spectral-domain (sd)-OCT. This system uses the superior and inferior quadrant RNFL thickness values, plotted on an x-y diagram for staging structural damage severity in glaucoma. A non-linear equation and two regression lines describe the boundary lines which separate the different sectors of the diagram. These mathematical formulas have been used to create a software, which provides a quick classification of the RNFL damage. Sensitivity and specificity of the system were assessed in a different cohort including 64 patients with early OAG, and 62 normal subjects.ResultsThree hundred and two OCT tests from 98 healthy controls and 284 patients affected by either ocular hypertension or chronic open-angle glaucoma were considered in order to design the new classification system. The OCT Glaucoma Staging System classifies RNFL defects into 6 stages of increasing severity ranging from borderline to stage 5, and 3 groups according to defect localization (superior, inferior, or diffuse). Sensitivity and specificity in discriminating between healthy and glaucomatous eyes were 95.2 and 91.9%, respectively, considering borderline results as abnormal.ConclusionsThe OCT Glaucoma Staging System appears to provide a standardized and objective classification of glaucomatous RNFL damage. It can be used in day-to-day clinical practice for an easy and fast interpretation of RNFL measurements obtained with OCT.

Entities:  

Mesh:

Year:  2017        PMID: 28776589      PMCID: PMC5770708          DOI: 10.1038/eye.2017.159

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  24 in total

1.  Reproducibility of retinal nerve fiber thickness measurements using the test-retest function of spectral OCT/SLO in normal and glaucomatous eyes.

Authors:  Sun Ho Lee; Seok Hwan Kim; Tae-Woo Kim; Ki Ho Park; Dong Myung Kim
Journal:  J Glaucoma       Date:  2010-12       Impact factor: 2.503

Review 2.  Staging functional damage in glaucoma: review of different classification methods.

Authors:  Paolo Brusini; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

3.  Comparison of glaucoma diagnostic Capabilities of Cirrus HD and Stratus optical coherence tomography.

Authors:  Seong Bae Park; Kyung Rim Sung; Sung Yong Kang; Kyung Ri Kim; Michael S Kook
Journal:  Arch Ophthalmol       Date:  2009-12

4.  Optic disc damage staging system.

Authors:  Paolo Brusini; Marco Zeppieri; Claudia Tosoni; Lucia Parisi; Maria Letizia Salvetat
Journal:  J Glaucoma       Date:  2010-09       Impact factor: 2.503

5.  Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments.

Authors:  Luisa Pierro; Marco Gagliardi; Lorenzo Iuliano; Alessandro Ambrosi; Francesco Bandello
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-31       Impact factor: 4.799

6.  Diagnostic capability of spectral-domain optical coherence tomography for glaucoma.

Authors:  Huijuan Wu; Johannes F de Boer; Teresa C Chen
Journal:  Am J Ophthalmol       Date:  2012-01-20       Impact factor: 5.258

7.  Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss.

Authors:  Christopher K S Leung; Marco Yu; Robert N Weinreb; Cong Ye; Shu Liu; Gilda Lai; Dennis S C Lam
Journal:  Ophthalmology       Date:  2012-01-20       Impact factor: 12.079

8.  Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography.

Authors:  J S Schuman; M R Hee; C A Puliafito; C Wong; T Pedut-Kloizman; C P Lin; E Hertzmark; J A Izatt; E A Swanson; J G Fujimoto
Journal:  Arch Ophthalmol       Date:  1995-05

9.  Comparison of the diagnostic ability of retinal nerve fiber layer thickness measured using time domain and spectral domain optical coherence tomography in primary open angle glaucoma.

Authors:  Lina Huang; Ning Fan; Xiaoli Shen; Jing He
Journal:  Eye Sci       Date:  2011-09

10.  Diagnostic ability of spectral-domain versus time-domain optical coherence tomography in preperimetric glaucoma.

Authors:  Jin Wook Jeoung; Tae-Woo Kim; Robert N Weinreb; Seok Hwan Kim; Ki Ho Park; Dong Myung Kim
Journal:  J Glaucoma       Date:  2014 Jun-Jul       Impact factor: 2.503

View more
  11 in total

1.  Clinical-Evolutionary Staging System of Primary Open-Angle Glaucoma Using Optical Coherence Tomography.

Authors:  Alfonso Parra-Blesa; Alfredo Sanchez-Alberca; Jose Javier Garcia-Medina
Journal:  J Clin Med       Date:  2020-05-19       Impact factor: 4.241

2.  Portable boom-type ultrahigh-resolution OCT with an integrated imaging probe for supine position retinal imaging.

Authors:  Zhengyu Duan; Kai Huang; Zhongzhou Luo; Ke Ma; Gengyuan Wang; Xiaodong Hu; Jinze Zhang; Xiaoling Luo; Yuancong Huang; Gangjun Liu; Xiaoyan Ding; Peng Xiao; Jin Yuan
Journal:  Biomed Opt Express       Date:  2022-05-10       Impact factor: 3.562

3.  Optical coherence tomography evaluation of retinal nerve fiber layer thickness in non-arteritic anterior ischemic optic neuropathy and primary open angle glaucoma: a systematic review and Meta-analysis.

Authors:  Yu-Xin Tong; Xin-Yu Zhang; Yi He; Zong-Lin Chen; Bing Jiang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

4.  Structure-function models for estimating retinal ganglion cell count using steady-state pattern electroretinography and optical coherence tomography in glaucoma suspects and preperimetric glaucoma: an electrophysiological pilot study.

Authors:  Derek Orshan; Andrew Tirsi; Hosam Sheha; Vasiliki Gliagias; Joby Tsai; Sung Chul Park; Stephen A Obstbaum; Celso Tello
Journal:  Doc Ophthalmol       Date:  2022-09-26       Impact factor: 1.854

5.  Elevated endothelin-1 levels as risk factor for an impaired ocular blood flow measured by OCT-A in glaucoma.

Authors:  Claudia Lommatzsch; Kai Rothaus; Lasse Schopmeyer; Maria Feldmann; Dirk Bauer; Swaantje Grisanti; Carsten Heinz; Maren Kasper
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

6.  Predicting Glaucoma Development With Longitudinal Deep Learning Predictions From Fundus Photographs.

Authors:  Terry Lee; Alessandro A Jammal; Eduardo B Mariottoni; Felipe A Medeiros
Journal:  Am J Ophthalmol       Date:  2021-01-07       Impact factor: 5.258

7.  Diagnostic ability of multifocal electroretinogram in early multiple sclerosis using a new signal analysis method.

Authors:  L Boquete; E López-Guillén; E Vilades; J M Miguel-Jiménez; L E Pablo; L De Santiago; M Ortiz Del Castillo; M C Alonso-Rodríguez; E M Sánchez Morla; A López-Dorado; E Garcia-Martin
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

8.  Volume of Lateral Geniculate Nucleus in Patients with Glaucoma in 7Tesla MRI.

Authors:  Ewa Kosior-Jarecka; Anna Pankowska; Piotr Polit; Andrzej Stępniewski; Mark Roger Symms; Paulina Kozioł; Tomasz Żarnowski; Radosław Pietura
Journal:  J Clin Med       Date:  2020-07-26       Impact factor: 4.241

9.  Investigation of Altered Spontaneous Brain Activities in Patients With Moyamoya Disease Using Percent Amplitude of Fluctuation Method: A Resting-State Functional MRI Study.

Authors:  Chu-Qi Li; Qian-Min Ge; Hui-Ye Shu; Xu-Lin Liao; Yi-Cong Pan; Jie-Li Wu; Ting Su; Li-Juan Zhang; Rong-Bin Liang; Yi Shao; Er-Ming Zeng
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

10.  Diagnostic Performance of the PalmScan VF2000 Virtual Reality Visual Field Analyzer for Identification and Classification of Glaucoma.

Authors:  Vijay Shetty; Prachi Sankhe; Suhas S Haldipurkar; Tanvi Haldipurkar; Rita Dhamankar; Priyanka Kashelkar; Dhruven Shah; Paresh Mhatre; Maninder Singh Setia
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.